...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: 50/50 at best on Zen being sold this year IMO..
Reply New Message
Back To Forum List View
50/50 at best on Zen being sold this year IMO..
3
fuzzyjr
May 13, 2020 01:29PM
Re: 50/50 at best on Zen being sold this year IMO..
1
dutchfella
May 13, 2020 02:14PM
Re: 50/50 at best on Zen being sold this year IMO..
1
fuzzyjr
May 13, 2020 02:27PM
Re: 50/50 at best on Zen being sold this year IMO..
2
fuzzyjr
May 13, 2020 02:49PM
Re: 50/50 at best on Zen being sold this year IMO..

dutchfella
May 13, 2020 03:53PM
Re: 50/50 at best on Zen being sold this year IMO..
1
fuzzyjr
May 13, 2020 04:02PM

You say they could not sell that 2million US offering at 2$when did they try? I don't remember a failed offering for Zenith.Please update me.

1 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply